Corticosteroid (CS)

DRUG2 trials

Sponsors

AbbVie, University of Calgary

Conditions

Giant Cell Arteritis (GCA)Rotator Cuff Injuries

Phase 3

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

CompletedNCT03725202

AbbVieGiant Cell Arteritis (GCA)

Start: 2019-01-24End: 2025-03-11Updated: 2026-02-24

Phase 4

The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial

CompletedNCT04743986

University of CalgaryRotator Cuff Injuries

Start: 2015-03-13End: 2019-06-06Updated: 2021-02-08

Related Papers

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

New England Journal of Medicine2025-04-0241 citations

Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

Arthritis Research & Therapy2024-06-058 citations